Circ_0049271 targets the miR-1197/PTRF axis to attenuate the malignancy of osteosarcoma

Yixin Wen1,1, Feng Xu1,1, Hui Zhang1

  • 1Orthopaedics Department, Fifth Hospital of Wuhan, Wuhan, Hubei, China.

Abstract

Insights

Circular RNA circ_0049271 inhibits osteosarcoma progression by targeting microRNA-1197 to regulate polymerase 1 and transcript release factor (PTRF). This suggests circ_0049271 as a potential therapeutic target for osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) play crucial roles in the development of osteosarcoma (OS).
  • Understanding the specific mechanisms of circRNAs in OS is vital for developing new treatments.

Purpose of the Study:

  • To investigate the functional role and underlying mechanisms of circ_0049271 in osteosarcoma progression.
  • To explore the regulatory relationship between circ_0049271, microRNA-1197 (miR-1197), and polymerase 1 and transcript release factor (PTRF) in OS.

Main Methods:

  • Cellular assays (colony formation, CCK-8, Transwell) were used to evaluate OS cell proliferation and invasion.
  • Quantitative reverse transcription-polymerase chain reaction and western blotting assessed expression levels of key molecules.
  • RNA immunoprecipitation and dual luciferase assays determined molecular interactions.
  • In vivo tumor formation assays evaluated the effect of circ_0049271 on tumor growth.

Main Results:

  • Osteosarcoma cells exhibited high miR-1197 expression and low circ_0049271 and PTRF levels.
  • circ_0049271 directly targeted miR-1197, thereby regulating PTRF expression.
  • Overexpression of circ_0049271 or PTRF suppressed OS cell proliferation and invasion, while miR-1197 upregulation promoted these processes.
  • circ_0049271 inhibited tumor growth in vivo, and PTRF overexpression counteracted the oncogenic effects of miR-1197.

Conclusions:

  • circ_0049271 functions as a tumor suppressor in osteosarcoma by targeting the miR-1197/PTRF axis.
  • This circRNA-mediated pathway offers a potential therapeutic strategy for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K